Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
258
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
-1.1M
-
Total reported value, excl. options
-
$2.39B
-
Value change
-
-$75.1M
-
Put/Call ratio
-
0.84
-
Number of buys
-
140
-
Number of sells
-
-102
-
Price
-
$84.04
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2019
291 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2019.
Medpace Holdings, Inc. - Common Stock (MEDP) has 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 30.9M outstanding shares and own 92.33% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.6M shares), VANGUARD GROUP INC (3.69M shares), WASATCH ADVISORS INC (1.41M shares), Pendal Group Ltd (1.26M shares), ACADIAN ASSET MANAGEMENT LLC (1.17M shares), STATE STREET CORP (792K shares), DIMENSIONAL FUND ADVISORS LP (761K shares), PRICE T ROWE ASSOCIATES INC /MD/ (742K shares), APG Asset Management N.V. (626K shares), and Invesco Ltd. (570K shares).
This table shows the top 258 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.